ホーム > 市場調査レポート > 医薬品

再生医療細胞治療

市場調査レポート

商品コード

1510611

アジア太平洋地域のバイオ生産市場：2030年予測- 地域別分析- 製品、用途、装置、エンドユーザー別

Asia Pacific Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 117 Pages
納期: 即納可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

アジア太平洋地域のバイオ生産市場は、2022年に47億9,134万米ドルと評価され、2030年には146億1,230万米ドルに達すると予測され、2022年から2030年までのCAGRは15.0%に達すると推定されます。

ブロックバスター生物製剤の特許失効がアジア太平洋地域のバイオ生産市場を押し上げる

生物学的製剤は、これまで不治の病であった疾患に対する有望な新しい治療法であり、医薬品市場において非常に重要な存在となっています。オリジネーターである生物学的製剤の特許は今後数年で失効すると予想されています。

最も売れている生物学的製剤の特許および独占権の推定満了日は以下の表の通りです。

生物学的製剤の有効期限

アバスチン2022年1月

サイラムザ 2023年5月

アドセトリス 2023年8月

アブスラックス 2024年10月

ガジーバ／ガジーバロ2024年11月

ダルザレックス 2026年5月

オクレバス 2027年4月

エムギャリティ 2028年9月

ヘムリブラ2028年2月

ルルメトリ2028年3月

イムフィンジ 2028年9月

マイロターグ 2028年4月

イムフィンジ 2028年9月

マイロタルグ 2028年4月

シルバント 2034年7月

オリジネーター生物学的製剤の特許切れやその他の知的財産権により、今後新たなバイオシミラーの導入が必要となります。その結果、市場競争は今後数年間、業界内で激化すると思われます。このように、ブロックバスター生物製剤の特許失効は、予測期間中にバイオ生産市場に有利な機会を創出すると予想されます。

アジア太平洋地域のバイオ生産市場概要

アジア太平洋地域のバイオ生産市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。優れた治療ソリューションへのニーズの高まり、研究開発活動への注力の増加、有利な規制シナリオなどの要因により、アジア太平洋地域の市場成長はより速いペースで成長すると予想されます。さらに、研究活動を後押しするための投資の増加とヘルスケアインフラの整備が、2022～2030年のアジア太平洋地域のバイオ生産市場を牽引すると推定されます。

中国では、ヘルスケア需要が急速に増加しています。老人人口の増加、慢性疾患の罹患率の上昇、ヘルスケア分野における政府のイニシアチブの増加といった要因が、中国の細胞療法市場を牽引しています。基本医療保険や民間医療保険制度の改善も、同国の医療セクターの成長を加速させています。所得水準の向上は、より高度なヘルスケア・サービスへの需要につながっています。老年人口の増加は、国内の専門医療機関の増加につながっています。中国では、がんの有病率の増加が細胞治療の採用を増加させると思われます。中国国家中央がん登録によると、中国では430万人の新規がん症例が登録されています。

アジア太平洋地域のバイオ生産市場の収益と2030年までの予測（金額）

アジア太平洋地域のバイオ生産市場セグメンテーション

アジア太平洋地域のバイオ生産市場は、製品、用途、装置、エンドユーザー、国に分類されます。

製品別では、アジア太平洋地域のバイオ生産市場は、生物製剤とバイオシミラー、ワクチン、細胞・遺伝子治療、核酸治療薬、その他に区分されます。生物製剤とバイオシミラーセグメントは、2022年にアジア太平洋地域のバイオ生産市場で最大のシェアを占めました。

用途別では、アジア太平洋地域のバイオ生産市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他に区分されます。2022年のアジア太平洋バイオ生産市場シェアは、がん分野が最大でした。

装置別では、アジア太平洋地域のバイオ生産市場は、アップストリーム装置、ダウンストリーム装置、バイオリアクター、消耗品・アクセサリーに分けられます。消耗品・付属品セグメントは、2022年にアジア太平洋地域のバイオ生産市場で最大のシェアを占めました。

エンドユーザー別では、アジア太平洋地域のバイオ生産市場はバイオ製薬会社、受託製造機関、その他に分類されます。バイオ製薬会社セグメントが2022年のアジア太平洋地域のバイオ生産市場で最大のシェアを占めています。

国別では、アジア太平洋地域のバイオ生産市場はオーストラリア、中国、インド、日本、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋地域のバイオ生産市場シェアは中国が独占。

Lonza Group AG、bbi-biotech GmbH、Danaher Corp、Sartorius AG、FUJIFILM Irvine Scientific Inc、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc.は、アジア太平洋地域のバイオ生産市場で事業を展開している大手企業の一部です。

List Of Tables

Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market

Product Code: BMIRE00030060

The Asia Pacific bioproduction market was valued at US$ 4,791.34 million in 2022 and is expected to reach US$ 14,612.30 million by 2030; it is estimated to register a CAGR of 15.0% from 2022 to 2030.

Patent Expiry of Blockbuster Biologics Boosts Asia Pacific Bioproduction Market

Biologicals represent promising new therapies for previously incurable diseases and are becoming highly important in the pharmaceuticals market. Patents on originator biologicals are expected to expire in the coming years.

Estimated patent and exclusivity expiry dates for best-selling biologicals are given in the following table.

Biologicals Expiry Dates

Avastin January 2022

Cyramza May 2023

Adcetris August 2023

Abthrax October 2024

Gazyva/Gazyvaro November 2024

Darzalex May 2026

Ocrevus April 2027

Emgality September 2028

Hemlibra February 2028

Llumetri March 2028

Imfinzi September 2028

Mylotarg April 2028

Imfinzi September 2028

Mylotarg April 2028

Sylvant July 2034

The patent expiration and other intellectual property rights for originator biologicals will create a need to introduce new biosimilars in the future. As a result, competition among market players will surge in the industry in the coming years. Thus, the patent expiry of blockbuster biologics is expected to create lucrative opportunities for the bioproduction market during the forecast period.

Asia Pacific Bioproduction Market Overview

The Asia Pacific bioproduction market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The growth of the market in Asia Pacific is anticipated to grow at a faster pace owing to factors such as growing need for superior treatment solutions, increasing focus on research and development activities, and favorable regulatory scenarios. Additionally, increasing investments and developing healthcare infrastructure to boost research activities are estimated to drive the Asia Pacific bioproduction market during 2022-2030.

In China, the demand for healthcare is increasing rapidly. Factors such as growing geriatric population, rising incidence of chronic diseases, and increasing government initiatives in the healthcare sector are driving the cell therapy market in China. Improvements in basic and private medical insurance plans have also accelerated the growth of the medical sector in the country. The rising income levels have led to the demand for more sophisticated healthcare services. The rise in the geriatric population has led to an increase in the specialty medical community in the country. In China, the growing prevalence of cancer is likely to increase the adoption of cell therapy. According to the National Central Cancer Registry of China, 4.3 million new cancer cases were registered in China.

Asia Pacific Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Bioproduction Market Segmentation

The Asia Pacific bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the Asia Pacific bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest Asia Pacific bioproduction market share in 2022.

In terms of application, the Asia Pacific bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest Asia Pacific bioproduction market share in 2022.

By equipment, the Asia Pacific bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest Asia Pacific bioproduction market share in 2022.

In terms of end user, the Asia Pacific bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest Asia Pacific bioproduction market share in 2022.

By country, the Asia Pacific bioproduction market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bioproduction market share in 2022.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the Asia Pacific bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - Asia Pacific Market Analysis

5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Asia Pacific: Bioproduction Market
- 10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
  - 10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 . Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 bbi-biotech GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Sartorius AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

アジア太平洋地域のバイオ生産市場：2030年予測- 地域別分析- 製品、用途、装置、エンドユーザー別

Asia Pacific Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

全表示

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章アジア太平洋地域のバイオ生産市場- 主要産業力学

第5章バイオ生産市場：アジア太平洋市場分析

第6章アジア太平洋地域のバイオ生産市場-製品別収益と2030年までの予測

第7章アジア太平洋地域のバイオ生産市場：用途別収益と2030年までの予測

第8章アジア太平洋地域のバイオ生産市場：装置別収益と2030年までの予測

第9章アジア太平洋地域のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章アジア太平洋地域のバイオ生産市場：国別収益と2030年までの予測

第11章バイオ生産市場-業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Bioproduction Market - Key Industry Dynamics

5. Bioproduction Market - Asia Pacific Market Analysis

6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product

7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application

8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User

10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

11. Bioproduction Market-Industry Landscape

12. Company Profiles

13. Appendix

アジア太平洋地域のバイオ生産市場：2030年予測- 地域別分析- 製品、用途、装置、エンドユーザー別

Asia Pacific Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

全表示

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 アジア太平洋地域のバイオ生産市場- 主要産業力学

第5章 バイオ生産市場：アジア太平洋市場分析

第6章 アジア太平洋地域のバイオ生産市場-製品別収益と2030年までの予測

第7章 アジア太平洋地域のバイオ生産市場：用途別収益と2030年までの予測

第8章 アジア太平洋地域のバイオ生産市場：装置別収益と2030年までの予測

第9章 アジア太平洋地域のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章 アジア太平洋地域のバイオ生産市場：国別収益と2030年までの予測

第11章 バイオ生産市場-業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Asia Pacific Bioproduction Market - Key Industry Dynamics

5. Bioproduction Market - Asia Pacific Market Analysis

6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product

7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application

8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User

10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

11. Bioproduction Market-Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章アジア太平洋地域のバイオ生産市場- 主要産業力学

第5章バイオ生産市場：アジア太平洋市場分析

第6章アジア太平洋地域のバイオ生産市場-製品別収益と2030年までの予測

第7章アジア太平洋地域のバイオ生産市場：用途別収益と2030年までの予測

第8章アジア太平洋地域のバイオ生産市場：装置別収益と2030年までの予測

第9章アジア太平洋地域のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章アジア太平洋地域のバイオ生産市場：国別収益と2030年までの予測

第11章バイオ生産市場-業界情勢

第12章企業プロファイル

第13章付録